[Design, synthesis and anti-HBV activity of L-amino acid ester prodrugs of acyclic nucleoside phosphonates]. 2008

Xiao-Zhong Fu, and Sai-Hong Jiang, and Yu-She Yang, and Ru-Yun Ji
School of Pharmacy, Guiyang Medical College, Guiyang 550004, China. xiaozhong_fu@sina.com

To design and synthesis a series of novel L-amino acid esters prodrugs of acyclic nucleoside phosphonates with more potent anti-HBV activity, adefovir dipivoxil was used as lead compound, according to the results of enhanced oral bioavailability and antiviral activities of nucleoside L-amino acid ester prodrugs. Eleven novel L-amino acid ester prodrugs of acyclic nucleoside phosphonates were designed and synthesized, their anti-HBV activities were evaluated in HepG2 2.2.15 cells. Eight compounds exhibited antiviral activity, and compound 11 showed the most potent anti-HBV activity and highest selective index in vitro (EC50 0.0952 micromol x L(-1), SI 69523). Moreover, by analyzing the primary structure and activity relationship of these compounds, it could be suggested that L-amino acid ester strategy has significant potential in the acyclic nucleoside phosphonates prodrug design.

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D009705 Nucleosides Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleoside,Nucleoside Analog,Nucleoside Analogs,Analog, Nucleoside,Analogs, Nucleoside
D011355 Prodrugs A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. Drug Precursor,Drug Precursors,Pro-Drug,Prodrug,Pro-Drugs,Precursor, Drug,Precursors, Drug,Pro Drug,Pro Drugs
D006515 Hepatitis B virus The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum. Dane Particle,Hepatitis Virus, Homologous Serum,B virus, Hepatitis,Hepatitis B viruses,Particle, Dane,viruses, Hepatitis B
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000596 Amino Acids Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins. Amino Acid,Acid, Amino,Acids, Amino
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D063065 Organophosphonates Carbon-containing phosphonic acid compounds. Included under this heading are compounds that have carbon bound to either OXYGEN atom or the PHOSPHOROUS atom of the (P Phosphonate,Phosphonates,Phosphonic Acid Esters,Acid Esters, Phosphonic,Esters, Phosphonic Acid

Related Publications

Xiao-Zhong Fu, and Sai-Hong Jiang, and Yu-She Yang, and Ru-Yun Ji
June 2019, ACS medicinal chemistry letters,
Xiao-Zhong Fu, and Sai-Hong Jiang, and Yu-She Yang, and Ru-Yun Ji
May 2013, European journal of medicinal chemistry,
Xiao-Zhong Fu, and Sai-Hong Jiang, and Yu-She Yang, and Ru-Yun Ji
May 2020, Bioorganic & medicinal chemistry letters,
Xiao-Zhong Fu, and Sai-Hong Jiang, and Yu-She Yang, and Ru-Yun Ji
September 2017, Bioorganic & medicinal chemistry,
Xiao-Zhong Fu, and Sai-Hong Jiang, and Yu-She Yang, and Ru-Yun Ji
August 2010, Yao xue xue bao = Acta pharmaceutica Sinica,
Xiao-Zhong Fu, and Sai-Hong Jiang, and Yu-She Yang, and Ru-Yun Ji
February 2005, The Journal of infectious diseases,
Xiao-Zhong Fu, and Sai-Hong Jiang, and Yu-She Yang, and Ru-Yun Ji
October 2005, Current protocols in nucleic acid chemistry,
Xiao-Zhong Fu, and Sai-Hong Jiang, and Yu-She Yang, and Ru-Yun Ji
January 2017, Mini reviews in medicinal chemistry,
Xiao-Zhong Fu, and Sai-Hong Jiang, and Yu-She Yang, and Ru-Yun Ji
May 2011, Yao xue xue bao = Acta pharmaceutica Sinica,
Xiao-Zhong Fu, and Sai-Hong Jiang, and Yu-She Yang, and Ru-Yun Ji
September 2006, Antiviral research,
Copied contents to your clipboard!